Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Saskia Middeldorp

Showing results (131-140 of 342) with videos related to

Pageof 35
Sort By:
Thrombosis Research|April 17, 2020
Progress of the ALIFE2 study: A dynamic road towards more evidenceEva N Hamulyák, Paulien G de Jong, Luuk J J Scheres, et al.
Thrombosis and Haemostasis|August 29, 2018
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonistsSuzanne M Bleker, Marjolein P A Brekelmans, Elise S Eerenberg, et al.
Journal of Thrombosis and Haemostasis : JTH|June 22, 2024
ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementationFionnuala Ní Áinle, Donna DiMichele, Yngve Falck-Ytter, et al.
Thrombosis and Haemostasis|August 18, 2017
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysisSuzanne M Bleker, Marjolein P A Brekelmans, Elise S Eerenberg, et al.
Thrombosis and Haemostasis|November 10, 2019
Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIαPeter van Doorn, Jan Rosing, Elena Campello, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2021
Sex-specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants-A substudy of the EINSTEIN-PE studyHanke M G Wiegers, Josien van Es, Ákos F Pap, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 30, 2011
[Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy]Jeanine E Roeters van Lennep, Elvera Meijer, Frans J C M Klumper, et al.
British Journal of Haematology|February 1, 2011
Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort studyRachel E J Roach, Sara Roshani, Karina Meijer, et al.
Fertility and Sterility|October 10, 2012
Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriageEmmy van den Boogaard, Danny M Cohn, Johanna C Korevaar, et al.
Thrombosis and Haemostasis|February 10, 2017
Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarinMarjolein P A Brekelmans, Luuk J J Scheres, Suzanne M Bleker, et al.
Pageof 35

Showing results (131-140 of 342) with videos related to

Sort By:
Pageof 35
Thrombosis Research|April 17, 2020
Progress of the ALIFE2 study: A dynamic road towards more evidenceEva N Hamulyák, Paulien G de Jong, Luuk J J Scheres, et al.
Thrombosis and Haemostasis|August 29, 2018
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonistsSuzanne M Bleker, Marjolein P A Brekelmans, Elise S Eerenberg, et al.
Journal of Thrombosis and Haemostasis : JTH|June 22, 2024
ISTH clinical practice guideline for treatment of congenital hemophilia A and B based on the Grading of Recommendations Assessment, Development, and Evaluation methodology: considerations for practice management and implementationFionnuala Ní Áinle, Donna DiMichele, Yngve Falck-Ytter, et al.
Thrombosis and Haemostasis|August 18, 2017
Clinical impact of major bleeding in patients with venous thromboembolism treated with factor Xa inhibitors or vitamin K antagonists. An individual patient data meta-analysisSuzanne M Bleker, Marjolein P A Brekelmans, Elise S Eerenberg, et al.
Thrombosis and Haemostasis|November 10, 2019
Development of a Plasma-Based Assay to Measure the Susceptibility of Factor V to Inhibition by the C-Terminus of TFPIαPeter van Doorn, Jan Rosing, Elena Campello, et al.
Journal of Thrombosis and Haemostasis : JTH|April 8, 2021
Sex-specific differences in clot resolution 3 weeks after acute pulmonary embolism managed with anticoagulants-A substudy of the EINSTEIN-PE studyHanke M G Wiegers, Josien van Es, Ákos F Pap, et al.
Nederlands Tijdschrift Voor Geneeskunde|April 30, 2011
[Thromboprophylaxis with low-molecular-weight heparin insufficient in high-risk pregnancy]Jeanine E Roeters van Lennep, Elvera Meijer, Frans J C M Klumper, et al.
British Journal of Haematology|February 1, 2011
Risk of cardiovascular disease in double heterozygous carriers and homozygous carriers of F5 R506Q (factor V Leiden) and F2 (prothrombin) G20210A: a retrospective family cohort studyRachel E J Roach, Sara Roshani, Karina Meijer, et al.
Fertility and Sterility|October 10, 2012
Number and sequence of preceding miscarriages and maternal age for the prediction of antiphospholipid syndrome in women with recurrent miscarriageEmmy van den Boogaard, Danny M Cohn, Johanna C Korevaar, et al.
Thrombosis and Haemostasis|February 10, 2017
Abnormal vaginal bleeding in women with venous thromboembolism treated with apixaban or warfarinMarjolein P A Brekelmans, Luuk J J Scheres, Suzanne M Bleker, et al.
Pageof 35